Short and long ‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 839-851, October 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Mar ía Chaparro,
Ana Garre,
Elena Ricart,
Marisa Iborra,
Francisco Mesonero,
Isabel Vera,
Sabino Riestra,
Valle García‐Sánchez,
M. Luisa De Castro,
Albert Martin‐Cardona,
Xavier Aldeguer,
Miguel Mínguez,
Manuel Barreiro de‐Acosta,
M Source Type: research
More News: Drugs & Pharmacology | Inflammatory Bowel Disease